Csenge Advisory Group’s CyrusOne Inc Common Stock CONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-3,222
Closed -$227K – 721
2021
Q4
$227K Buy
+3,222
New +$273K 0.02% 501
2021
Q3
– Sell
-3,222
Closed -$227K – 625
2021
Q2
$227K Hold
3,222
– – 0.02% 504
2021
Q1
$224K Sell
3,222
-96
-3% -$6.66K 0.02% 455
2020
Q4
$243K Buy
3,318
+30
+0.9% +$2.18K 0.03% 370
2020
Q3
$254K Buy
+3,288
New +$258K 0.03% 326
2020
Q1
– Sell
-3,391
Closed -$222K – 354
2019
Q4
$222K Sell
3,391
-105
-3% -$7.21K 0.06% 263
2019
Q3
$277K Sell
3,496
-505
-13% -$33.7K 0.08% 217
2019
Q2
$231K Sell
4,001
-80
-2% -$4.69K 0.08% 169
2019
Q1
$214K Hold
4,081
– – 0.07% 184
2018
Q4
$215K Buy
4,081
+999
+32% +$57.1K 0.08% 174
2018
Q3
$167K Buy
+3,082
New +$199K 0.06% 184

Other funds holding CONE

Csenge Advisory Group's CONE Position: Q1 2022 in Review

Csenge Advisory Group sold out of CyrusOne Inc Common Stock (CONE) in Q1 2022, closing a stake of 3,222 shares — an estimated $227K sold.

Csenge Advisory Group first reported a position in CONE in Q3 2018 and held it in 11 quarters. The position peaked at $277K in Q3 2019. 3 funds tracked by Wall St. Rank hold CONE as of Q1 2022.

  • Csenge Advisory Group reported no remaining CyrusOne Inc Common Stock position as of Q1 2022 after selling out during the quarter.
  • Csenge Advisory Group sold 3,222 CyrusOne Inc Common Stock shares in Q1 2022, an estimated $227K.
  • Csenge Advisory Group first reported a position in CyrusOne Inc Common Stock in Q3 2018 and held it in 11 quarters.
  • Csenge Advisory Group's CyrusOne Inc Common Stock position peaked at $277K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held CyrusOne Inc Common Stock as of Q1 2022.

Based on Csenge Advisory Group's 13F filing for Q1 2022, filed 9 May 2022.